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Chronic mucocutaneous candidiasis (CMC) is characterized by Candida infection
of the mucous membrane, scalp, skin and nails. We present a case of a 42-year-
old man who was treated twice in the Dermatological Department. He was
admitted the first time as a 7-year-old boy because of skin and mucosal lesions
and then the diagnosis of granuloma candidamyceticum was established. Thirty-
one years later he was admitted again with a history of facial skin lesions and
blepharitis. For a couple of years he had suffered from diabetes and
hypothyroidism. The diagnosis of CMC with endocrinopathy was established in
our patient.
Key words: chronic mucocutaneous candidiasis, Candida albicans, endocrinopathy,
hypothyroidism.
Introduction
Chronic mucocutaneous candidiasis (CMC) refers to a heterogeneous
group of disorders characterized by recurrent or persistent superficial
infections of the skin, mucous membranes, and nails with Candida
organisms, usually C. albicans [1-3]. Classification criteria are based on the
association with other diseases, type of inheritance and disease onset and
were categorized by Coleman and Hay (Table I) [1]. Provisional diagnosis
of CMC can be established based on the clinical findings. Microscopy 
and culture of skin swabs and scrapings confirm the presence of
microorganisms [4]. 
We present a rare case of a 42-year-old male patient with CMC and
hypothyroidism with the coexistence of diabetes mellitus. The patient gave
written informed consent for his case report to be published.
Case report 
A 7-year-old Caucasian boy was admitted to the Department of
Dermatology in 1974 with a history of recurrent whitish plaque in the oral
cavity and skin lesions since eight months of life. From his first months of
life he suffered from recurrent pulmonary infections. On admission he
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Erythemato-squamous serpiginous plaques were
observed on the trunk and legs, and erythematous,
hyperkeratotic skin lesions were located on the
scalp. Examination of the oral cavity revealed
angular cheilitis. The fingernails were thickened,
fragmented, discoloured, with significant oedema
and erythema of the surrounding periungual tissue.
No changes were observed within the toenails.
Familial history for genetic pathologies or
immunodeficiency was negative. Scrapings from
the infected site showed the presence of yeast cells
and pseudohyphae. Culture for fungi in Sabouraud's
agar presented growth of C. albicans. Blood count
analysis showed anaemia, leukocytosis and
glycaemia. Thyroid hormones, calcium and
phosphorus were normal. Only a very high level of
total cholesterol was noted (480 mg%). IgG1 and
IgA values were above normal. Intradermal
cutaneous test with tardive reading was strongly
positive for candidin from 24-72 h and negative for
trichophytin. The blastic transformation of the
patient’s lymphocytes with phytohaemagglutinin
was 80% of functional capacity against a control,
demonstrating a slight decrease in the functional
capacity of the lymphocytes. The mitotic index was
lower than in normal controls (47%). The patient
was diagnosed with granuloma candidamyceticum.
Treatment was initiated with oral natamycin (50 mg
every 6 h) and with topical antifungal specimens
(clotrimazole cream 3 times a day). Because of
pharyngitis he was treated with sulphonamides
(sulfamerazine and sulphaproxyline in suspension
9 ml/twice daily). A satisfactory result was obtained,
with disappearance of the lesions after 2 weeks of
treatment. Thirty-one years later he was admitted
once again to our department with a 4-month
history of persistent scaling, erythematosus facial
skin lesions and blepharitis. He had suffered from
diabetes type 1 for 11 years and was being treated
with insulin (dose dependent on glycaemia level).
Two years before admission arterial hypertension
(enalapril 5 mg/twice daily) and autoimmune
hypothyroidism (L-thyroxine 100 µg/day) were
diagnosed. Temporarily he suffered from respiratory
tract infections and recurrent mucous membrane
lesions which required treatment with topical
antifungal agents and fluconazole. Within this
period the patient was being treated by a GP and
was not hospitalized in a dermatological unit. Oral
cavity examination revealed white patches
scattered over buccal, palatal and labial mucosa
and a fissured tongue. The diagnosis of acute
atrophic and pseudomembranous candidiasis of the
oral cavity was established (Figure 1). Fingernails of
both hands showed onycholysis, onychorrhexis and
onychodystrophy. No periungual inflammatory
lesions were noted. Toenails were unchanged. KOH
examination from skin lesions (forehead, eyelids)
and oral mucosal membranes (tongue and buccae)
was positive for yeast cells. The culture was positive
for C. albicans. Mycological samples (KOH and
culture) from nails were negative. Blood count
showed slight anaemia (RBC – 3.5 × 106/mm3, HGB
– 10.6 g/dl, HCT – 34.2%) and hyperglycaemia 
(134 mg/dl). The patient is being followed up in the
Diabetic Outpatient Department and the disease is
partially controlled. On admission to our
department the patient was administered with 
L-thyroxine and no abnormalities in total
cholesterol, liver enzymes or T3, T4 and TSH levels
were found. Also antithyroid autoantibodies were
within the normal range. HIV test was negative. The
blastic transformation of the patient’s lymphocytes
with phytohaemagglutinin and the mitotic index
were as in normal controls. Endocrine screening
tests including prolactin, testosterone and
parathyroid-stimulating hormone were within
normal levels. In the evaluation of humoral
immunity, the following serum levels were obtained:
IgG1 = 17.6 g/l (7-14 g/l), IgM = 0.9 g/l (0.4-2.3 g/l),
IgA = 4.6 g/l (0.7-4 g/l). 
Treatment with fluconazole and topical
antifungal medications was unsuccessful. After 
2 months of itraconazole therapy (100 mg/daily)
disappearance of the lesions was noted (Figure 2).
The patient was followed up to three years without
recurrence. The patient is a bachelor and has no
children. 
Association with other disease Pattern of inheritance Onset
Without endocrinopathy Recessive Childhood
With endocrinopathy autoimmune polyendocrinopathy Recessive Childhood
Without endocrinopathy Dominant Childhood
With endocrinopathy with hypothyroidism Dominant Childhood
Sporadic CMC Unknown Childhood
CMC with keratitis Unknown  Childhood
Late-onset CMC with thymoma Unknown Adult
Table I. Types of CMC
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Discussion
Coleman and Hay [1] described 2 families with
a new syndrome characterized by hypothyroidism
and CMC with dominant inheritance. Myhre et al.
[5] also described 2 families with CMC (with main
manifestations of facial seborrhoeic dermatitis,
generalized folliculitis and scaling dermatitis) and
hypothyroidism, which became evident during
childhood. In contrast, the presented patient
developed similar facial lesions and thyroid gland
insufficiency only in adulthood. Spanish authors
described CMC in an uncommon form of candidiasis
granuloma and hypothyroidism [6]. In our patient
also granuloma candidamyceticum was diagnosed
during childhood, but then it was not accompanied
by internal organ failure. Atkinson et al. [7]
described a family with a combination of CMC and
thyroid disease, segregating as an autosomal
dominant trait with reduced penetrance. In our
patient genetic tests were not performed; however,
based on the medical history a genetic background
may be excluded. 
The pathomechanism of CMC is still not fully
known. Complement function, neutrophil
phagocytosis and intracellular killing are believed
to be among the factors involved in disease
development. Patients may have high titres of IgG1
and IgA, with or without IgG2 subclass deficiency,
which was noted in our patient. The blastic
transformation test of the patient’s lymphocytes
and mitotic index demonstrated a slight decrease
in the functional capacity of the lymphocytes in
childhood while in adulthood they were not
observed. Immunological studies of patients with
CMC often reveal defects related to cell-mediated
Figure 1. Clinical picture of facial skin lesions (A) 
and mucosal (B) changes
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Figure 2. Clinical picture of the face (A) and oral cavity (B) after 2 months of treatment with itraconazole
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immunity, but the defects themselves vary widely.
The true details of the defects associated with CMC
syndrome remain poorly understood. Results from
cellular immunity tests, such as the prick-test with
Candida antigens, may be negative, but in our patient
the intradermal cutaneous test with tardive reading
was strongly positive for candidin, which may
suggest no defects in cell-mediated immunity [8]. 
Literature data indicate that in response to
Candida antigen patients with CMC have impaired
cytokine synthesis, with insufficient production of
Th1-derived cytokines rather than overproduction
of type 2 [3, 9]. Treatment with topical and systemic
antimycotic drugs results in temporary recovery,
but it is unable to reach a complete remission [10].
In the presented case therapy with itraconazole
resulted in a 3-year remission of skin and mucosal
lesions. 
Based on the clinical picture and laboratory
findings the diagnosis of CMC with endocrinopathy
was established in our patient. The presented case
also shows that a childhood onset of skin lesions
typical for CMC may be the first sign of subsequent
development of endocrine failure.
Patients and their families should be informed
of the chronic and recurrent nature of the disease
and the necessity of frequent antifungal treatment.
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